From cataract to syndrome diagnosis: Revaluation of Warburg-Micro syndrome Type 1 patients


Albayrak H., ELÇİOĞLU H. N., Yeter B., Karaer K.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A, cilt.185, sa.8, ss.2325-2334, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 185 Sayı: 8
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1002/ajmg.a.62234
  • Dergi Adı: AMERICAN JOURNAL OF MEDICAL GENETICS PART A
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Applied Science & Technology Source, BIOSIS, CAB Abstracts, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.2325-2334
  • Anahtar Kelimeler: congenital cataract, corpus callosum hypo, agenesia, RAB3GAP1, Warburg&#8208, Micro syndrome, CONGENITAL CATARACT, HEAD CIRCUMFERENCE, MENTAL-RETARDATION, RAB3GAP1 MUTATIONS, RAB18, HYPOGENITALISM, PROTEINS, WEIGHT
  • Ankara Üniversitesi Adresli: Evet

Özet

Warburg-Micro syndrome (WARBM) is a rare autosomal recessively inherited neuro-ophthalmologic syndrome. Although WARBM shows genetic heterogeneity, the pathogenic variants in RAB3GAP1 were the most common cause of WARBM. In this study, we aimed to evaluate the detailed clinical and dysmorphic features of seven WARBM1 patients and overview the variant spectrum of RAB3GAP1 in comparison with the literature who were referred due to congenital cataracts. A previously reported homozygous variant (c.2187_2188delGAinsCT) was identified in three of these patients, while the other four had three novel variants (c.251_258delAGAA, c.2606+1G>A, and c.2861_2862dupGC). Congenital cataract and corpus callosum hypo/agenesia are pathognomonic for WARBM, which could be distinguished from other similar syndromes with additional typical dysmorphic facial features. Although there is no known phenotype and genotype correlation in any type of WARBM, RAB3GAP1 gene analysis should be previously requested as the first step of genetic diagnosis in clinically suspicious patients when it is not possible to request a multi-gene panel.